Pharmacogenetic studies update in type 2 diabetes mellitus

doi:10.4239/wjd.v7.i15.302

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 15

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13936)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

1450

WORD

366

HTML

8277

Figures (1-5)

307

Tables (1-1)

157

Sum=10557

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

436

Download

784

Sum=1220

Publishing Process of This Article

Item

Count

Browse

1026

Download

1133

Sum=2159

Aug 10, 2016 (publication date) through Jul 2, 2024

Times Cited of This Article

Times Cited (39)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Diabetes. Aug 10, 2016; 7(15): 302-315
Published online Aug 10, 2016. doi: 10.4239/wjd.v7.i15.302

Full Size Figure Download Figure

Figure 4 Schematic representations of peroxisome prolierator-activated receptor γ variants affecting the efficacy of thiazolidinediones. TZDs: Thiazolidinediones; PPARγ: Peroxisome proliferator-activated receptor γ.

Citation: Singh S, Usman K, Banerjee M. Pharmacogenetic studies update in type 2 diabetes mellitus. World J Diabetes 2016; 7(15): 302-315
URL: https://www.wjgnet.com/1948-9358/full/v7/i15/302.htm
DOI: https://dx.doi.org/10.4239/wjd.v7.i15.302